36 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
for driving employee engagement and operational excellence,” said Carl Hull, Executive Chairman of Maravai. “Through my personal and professional
8-K
EX-10.1
8ie0h54
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
d4yd4g8b7v wr
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
DEF 14A
wgeobiqs6gq kegvuya3
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
fybk0q5 s1
9 Apr 21
Preliminary proxy
4:16pm
424B4
ze7 ijair2
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
v6j1fxis661z4atzsns6
25 Mar 21
Draft registration statement
12:00am
8-K
EX-10.1
44vacqcoau
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.5
v68 ezfqofslmnqg
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.1
glmo59z xzrgu91sm
23 Nov 20
Registration of securities for employees
5:06pm
424B4
2741a1gn 28vtjr49fo
23 Nov 20
Prospectus supplement with pricing info
4:36pm